218 related articles for article (PubMed ID: 22370987)
1. [Small biopsies and cytologic specimens management in microscopic diagnosis and subtyping of non-small cell lung cancer, as recommended by IASLC/ATS/ERS].
Langfort R; Szołkowska M; Szczepulska-Wójcik E; Maksymiuk B
Pneumonol Alergol Pol; 2012; 80(2):172-7. PubMed ID: 22370987
[No Abstract] [Full Text] [Related]
2. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.
Rodriguez EF; Monaco SE; Dacic S
Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235
[TBL] [Abstract][Full Text] [Related]
3. [Changes in classiffication of primary lung adenocarcinoma according to reccomendations of International Association for the Study of Lung Cancer/ /American Thoracic Society/European Respiratory Society].
Szołkowska M; Langfort R; Szczepulska-Wójcik E; Maksymiuk B
Pneumonol Alergol Pol; 2012; 80(2):163-71. PubMed ID: 22370986
[No Abstract] [Full Text] [Related]
4. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
Rodriguez EF; Dacic S; Pantanowitz L; Khalbuss WE; Monaco SE
Cancer Cytopathol; 2015 May; 123(5):306-17. PubMed ID: 25788465
[TBL] [Abstract][Full Text] [Related]
5. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
[TBL] [Abstract][Full Text] [Related]
6. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact.
Sterlacci W; Savic S; Schmid T; Oberaigner W; Auberger J; Fiegl M; Tzankov A
Am J Clin Pathol; 2012 Jun; 137(6):946-56. PubMed ID: 22586054
[TBL] [Abstract][Full Text] [Related]
7. [Recommendation concerning the microscopic classification of lung adenocarcinoma presented by International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society].
Langfort R; Szołkowska M
Pneumonol Alergol Pol; 2012; 80(2):99-100. PubMed ID: 22370977
[No Abstract] [Full Text] [Related]
8. Staging of non-small cell lung cancer (NSCLC): a review.
Tsim S; O'Dowd CA; Milroy R; Davidson S
Respir Med; 2010 Dec; 104(12):1767-74. PubMed ID: 20833010
[TBL] [Abstract][Full Text] [Related]
9. [The international multidisciplinary classification of lung adenocarcinoma from IASLC/ATS/ERS and problems in clinical practice].
Yan L; Yi X
Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):333-8. PubMed ID: 23866662
[TBL] [Abstract][Full Text] [Related]
10. [Comments on International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society (IASLC/ATS/ERS) International Multidisciplinary Classification of Lung Adenocarcinoma (2011)].
Huang SF
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):793-6. PubMed ID: 22336202
[No Abstract] [Full Text] [Related]
11. [Are the ATS (American Thoracic Society) and the ERS (European Respiratory Society) correct in not recommending routine tumor marker assays foeening, staging, or evaluation of non-small cell lung cancer?].
Watine J; Charet JC
Rev Mal Respir; 1999 Apr; 16(2):139-49. PubMed ID: 10339757
[TBL] [Abstract][Full Text] [Related]
12. [The new TNM classification in lung cancer].
Wrona A; Jassem J
Pneumonol Alergol Pol; 2010; 78(6):407-17. PubMed ID: 21077033
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer staging: proposed revisions to the TNM system.
Schneider BJ
Cancer Imaging; 2008 Sep; 8(1):181-5. PubMed ID: 18824424
[TBL] [Abstract][Full Text] [Related]
14. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.
Travis WD; Brambilla E; Riely GJ
J Clin Oncol; 2013 Mar; 31(8):992-1001. PubMed ID: 23401443
[TBL] [Abstract][Full Text] [Related]
15. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
16. Bronchial biopsies--in praise of an H&E section.
Pandit D; Griffiths D; Edwards J
Histopathology; 2006 Jul; 49(1):96-7. PubMed ID: 16842256
[No Abstract] [Full Text] [Related]
17. Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification.
Travis WD; Brambilla E; Van Schil P; Scagliotti GV; Huber RM; Sculier JP; Vansteenkiste J; Nicholson AG
Eur Respir J; 2011 Aug; 38(2):239-43. PubMed ID: 21804158
[No Abstract] [Full Text] [Related]
18. Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing.
Travis WD; Rekhtman N
Semin Respir Crit Care Med; 2011 Feb; 32(1):22-31. PubMed ID: 21500121
[TBL] [Abstract][Full Text] [Related]
19. Genes and pathology of non-small cell lung carcinoma.
Sakashita S; Sakashita M; Sound Tsao M
Semin Oncol; 2014 Feb; 41(1):28-39. PubMed ID: 24565579
[TBL] [Abstract][Full Text] [Related]
20. Non-small-cell lung carcinoma subtyping on cytology without the use of immunohistochemistry - can we meet the challenge?
Manucha V; Wang C; Huang Y
Acta Cytol; 2012; 56(4):413-8. PubMed ID: 22846184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
